These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14604700)

  • 1. Topical corticosteroids after keratorefractive surgery.
    Annonier P
    J Cataract Refract Surg; 2003 Oct; 29(10):1853-4. PubMed ID: 14604700
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical corticosteroids after keratorefractive surgery.
    Price FW
    J Cataract Refract Surg; 2002 Aug; 28(8):1307; author reply 1307-8. PubMed ID: 12160777
    [No Abstract]   [Full Text] [Related]  

  • 3. A prospective, randomized comparison of the use versus non-use of topical corticosteroids after laser in situ keratomileusis.
    Price FW; Willes L; Price M; Lyng A; Ries J
    Ophthalmology; 2001 Jul; 108(7):1236-44; discussion 1244-5. PubMed ID: 11425681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interlamellar flap edema due to steroid-induced ocular hypertension after laser in situ keratomileusis.
    Miyai T; Yonemura T; Nejima R; Otani S; Miyata K; Amano S
    Jpn J Ophthalmol; 2007; 51(3):228-30. PubMed ID: 17554487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interface fluid after LASIK: misleading tonometry can lead to end-stage glaucoma.
    Najman-Vainer J; Smith RJ; Maloney RK
    J Cataract Refract Surg; 2000 Apr; 26(4):471-2. PubMed ID: 10819625
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cataract surgery and eye drops--is a drop only a habit?].
    Oskala P; Carlson P
    Duodecim; 2002; 118(15):1565-9. PubMed ID: 12244631
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical cyclosporine A for postoperative photorefractive keratectomy and laser in situ keratomileusis.
    Hessert D; Tanzer D; Brunstetter T; Kaupp S; Murdoch D; Mirzaoff M
    J Cataract Refract Surg; 2013 Apr; 39(4):539-47. PubMed ID: 23415779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of pain with diclofenac after femtosecond-assisted laser in situ keratomileusis.
    Parker J; Tandon A; Shtein RM; Soong HK; Cooney TN; Musch DC; Mian SI
    J Cataract Refract Surg; 2011 Mar; 37(3):569-73. PubMed ID: 21262562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular therapeutics.
    Albietz J; Douglas I; Napper G
    Clin Exp Optom; 2004 Mar; 87(2):124-5. PubMed ID: 15106590
    [No Abstract]   [Full Text] [Related]  

  • 10. Interface fluid after laser in situ keratomileusis.
    Fogla R; Rao SK; Padmanabhan P
    J Cataract Refract Surg; 2001 Sep; 27(9):1526-8. PubMed ID: 11566545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectasia after LASIK: new treatments, new hope.
    Randleman JB
    J Refract Surg; 2011 May; 27(5):319. PubMed ID: 21553755
    [No Abstract]   [Full Text] [Related]  

  • 12. Diffuse lamellar keratitis: diagnosis and management.
    Linebarger EJ; Hardten DR; Lindstrom RL
    J Cataract Refract Surg; 2000 Jul; 26(7):1072-7. PubMed ID: 10946202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin analogs may aggravate myopic regression after laser in situ keratomileusis.
    Nowroozzadeh MH
    Am J Ophthalmol; 2009 Apr; 147(4):754; author reply 754-5. PubMed ID: 19327446
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM; McDonald MB; Smolek M
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive corneal epithelial defect associated with internal hordeolum after uneventful laser in situ keratomileusis.
    Maldonado MJ; Juberías JR; Moreno-Montañés J
    J Cataract Refract Surg; 2002 Sep; 28(9):1700-2. PubMed ID: 12231335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progresses in antiinflamatory treatment in cataract surgery].
    Stefan C; Pop A; Cojocaru I
    Oftalmologia; 2011; 55(3):89-93. PubMed ID: 22428297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic toxicity of topical corticosteroids.
    Jinagal J; Gupta PC; Pilania RK; Ram J
    Indian J Ophthalmol; 2019 Apr; 67(4):559-561. PubMed ID: 30900600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antiglaucoma drugs on refractive outcomes in eyes with myopic regression after laser in situ keratomileusis.
    Kamiya K; Aizawa D; Igarashi A; Komatsu M; Shimizu K
    Am J Ophthalmol; 2008 Feb; 145(2):233-238. PubMed ID: 18054889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and management of post-LASIK dry eye syndrome.
    Rosenfeld SI
    Int Ophthalmol Clin; 2010; 50(3):191-9. PubMed ID: 20611028
    [No Abstract]   [Full Text] [Related]  

  • 20. Cogan syndrome presenting after uneventful laser in situ keratomileusis.
    Tomita M; Chiba A; Inoue N; Huseynova T; Tsuru T; Waring GO
    J Cataract Refract Surg; 2013 Aug; 39(8):1260-6. PubMed ID: 23889869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.